Bluebird, PsiOxus show oncolytic virus boosts CAR-T in solid tumors

Bluebird bio has shown cancer gene therapy vectors boost the efficacy of its CAR-T therapy in mice. The study assessed the effect of giving bluebird’s anti-EGFR CAR-T cells in combination with vectors in development at PsiOxus Therapeutics.